NIMSLON-1

Description

Methylprednisolone Sodium Succinate 1 g Injection is a fast-acting corticosteroid used to treat severe inflammation, autoimmune conditions, and life-threatening allergic reactions. This injection is typically administered intravenously (IV) or intramuscularly (IM) for rapid relief.

Composition:

• Methylprednisolone Sodium Succinate – 1 g/vial

Indications:

Used for the treatment of:

• Severe Allergic Reactions (Anaphylaxis)
• Septic Shock
• Autoimmune Disorders (Lupus, Multiple Sclerosis)
• Acute Asthma Attacks
• Severe Skin Conditions (Pemphigus, Psoriasis)
• Organ Transplant Rejection Prevention
• Cerebral Edema (Brain Swelling)

Dosage and Administration:

✅ Route of Administration:

• Intravenous (IV) – Preferred for emergency and critical cases.
• Intramuscular (IM) – For sustained systemic effect.

✅ Dosage Guidelines:

• Adults: 1 g IV over 30-60 minutes (may repeat based on condition).
• Pediatric: Adjust based on body weight (usually 30 mg/kg).
• Tapering Required: Gradually reduce dosage to avoid adrenal insufficiency.

Precautions and Warnings:

• Not for Long-Term Use: Prolonged use may cause adrenal suppression.
• Diabetes & Hypertension: Monitor blood sugar and blood pressure.
• Pregnancy Category C: Use only if necessary under medical supervision.
• Infections: Avoid use in patients with active fungal infections.
• Caution in Elderly: Monitor for osteoporosis and muscle weakness.

Side Effects:

• Hyperglycemia (Increased blood sugar)
• Hypertension (Increased blood pressure)
• Mood Changes (Irritability, Anxiety)
• Nausea or Vomiting
• Increased Risk of Infection

Packaging Details:

• Strength: 1 g/vial
• Form: Powder for reconstitution (IV/IM use)
• Packaging: Single-use vial with sterile diluent

Why Choose Our Methylprednisolone Sodium Succinate Injection?

• WHO-GMP Certified for quality and efficacy.
• Fast-acting for critical care situations.
• Available for PCD Pharma Franchise and Third Party Manufacturing.